advertisement

Prostate cancer

03 June 2010

Value of Monitoring Low-Risk Prostate Cancer Assessed

'Watchful waiting' may be option for some men, expert suggests

This article has not necessarily been edited by Health24.

In one preliminary study, researchers in Canada studied 453 men with lower-risk prostate cancer and determined how many would have been offered treatment instead of monitoring based on such commonly used "triggers" as measurements of prostate-specific antigen (PSA). The rates ranged from 42 percent to 84 percent.

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.